NEU 2.99% $20.10 neuren pharmaceuticals limited

Management have been very clear in their messaging, 2591 read...

  1. 2,167 Posts.
    lightbulb Created with Sketch. 571
    Management have been very clear in their messaging, 2591 read outs the goal post, dividends unlikely.

    The strategy is it seems here is they will have close to $200m AUD on hand by years end (variables ROW upfront and expenditure), puts them in good negotiation position of partnering 2591 or in fact a TO event.

    Make no mistakes management know the value of these assets/pipeline including the x 100 potential, given what seems the strategy to maximise value of the assets/pipeline, I think they would be very cautious about what they would put forward to share holders given some of the low ball figures some would be happy with, clearly not recognising the true value of Trof asset let alone 2591.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.